• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVH

AVITA MEDICAL INC. - Announcements

0.75% ! $1.34
Market Cap $121.4M  !

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies... AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
AVH Burns Research presented at UK Skin Regeneration Symposium-AVH.AX PRICE SENSITIVE19/04/16 download Created with Sketch. 76.47KB
AVH Avita completes Enrollment for Repigmentation StudyPRICE SENSITIVE15/03/16 download Created with Sketch. 124.6KB
AVH Signs China Distributor Deal with largest healthcare GroupPRICE SENSITIVE11/03/16 download Created with Sketch. 60.63KB
AVH Positive Results from Multicentre EU Study Venous Leg UlcersPRICE SENSITIVE09/03/16 download Created with Sketch. 137.57KB
AVH FDA increases Compassionate Use of ReCell Patient CasesPRICE SENSITIVE07/03/16 download Created with Sketch. 58.32KB
AVH Half Year Report and AccountsPRICE SENSITIVE26/02/16 download Created with Sketch. 465.21KB
AVH ReCell Distributor appointed Germany Austria and SwitzerlandPRICE SENSITIVE11/02/16 download Created with Sketch. 102.17KB
AVH Divestment of Respiratory BusinessPRICE SENSITIVE05/02/16 download Created with Sketch. 118.98KB
AVH Avita Medical Quarterly Cashflow Activities and ReportPRICE SENSITIVE28/01/16 download Created with Sketch. 150.1KB
AVH Avita Medical Appoints Distributors in Japan and South KoreaPRICE SENSITIVE14/01/16 download Created with Sketch. 95.84KB
AVH Avita completes FDA patient recruitment for ReCell TrialPRICE SENSITIVE11/01/16 download Created with Sketch. 486.1KB
AVH MVP acquires Avita Medicals Australian Respiratory BusinessPRICE SENSITIVE24/12/15 download Created with Sketch. 305.58KB
AVH FDA Grants Avita's ReCell Expedited Access PathwayPRICE SENSITIVE14/12/15 download Created with Sketch. 127.84KB
AVH Avita Medical Reports 63% Decreased Length of Hospital StayPRICE SENSITIVE09/12/15 download Created with Sketch. 125.31KB
AVH Avita Medical appoints ReCell Distributors in UK & FrancePRICE SENSITIVE24/11/15 download Created with Sketch. 215.55KB
AVH Avita Medical Extends ReCell IP Patent through to 2033PRICE SENSITIVE18/11/15 download Created with Sketch. 289.8KB
AVH Avita Medical Quarterly ReportPRICE SENSITIVE28/10/15 download Created with Sketch. 227.1KB
AVH Power of ReCell Results presented at European Burns CongressPRICE SENSITIVE27/10/15 download Created with Sketch. 293.42KB
AVH First Patient Treated in US Military Wound TrialPRICE SENSITIVE22/10/15 download Created with Sketch. 293.17KB
AVH Avita ReCell Findings Published in Leading Medical JournalPRICE SENSITIVE21/10/15 download Created with Sketch. 372.46KB
AVH Avita Medical Closes AUD$10M Equity FinancingPRICE SENSITIVE20/10/15 download Created with Sketch. 97.09KB
AVH Trading HaltPRICE SENSITIVE16/10/15 download Created with Sketch. 83.75KB
AVH Avita Medical ReCell Update on Treatment Taiwan Burn VictimsPRICE SENSITIVE13/10/15 download Created with Sketch. 228.01KB
AVH Avita Medical Gains CE Mark for its Skin Healing PortfolioPRICE SENSITIVE07/10/15 download Created with Sketch. 304.39KB
AVH FDA Doubles Patient Numbers Permitted for Compassionate UsePRICE SENSITIVE05/10/15 download Created with Sketch. 124.25KB
AVH Avita Medical Secures USD$53.9m ContractPRICE SENSITIVE30/09/15 download Created with Sketch. 103.11KB
AVH Avita Medical Patent Validated in Eleven European CountriesPRICE SENSITIVE02/09/15 download Created with Sketch. 115.22KB
AVH Reinstatement to Official QuotationPRICE SENSITIVE31/08/15 download Created with Sketch. 28.02KB
AVH US Mass Casualty Preparedness Achieves High RatingPRICE SENSITIVE31/08/15 download Created with Sketch. 74.64KB
AVH Suspension from Official QuotationPRICE SENSITIVE28/08/15 download Created with Sketch. 28.26KB
AVH Preliminary Final ReportPRICE SENSITIVE27/08/15 download Created with Sketch. 148.49KB
AVH Trading HaltPRICE SENSITIVE26/08/15 download Created with Sketch. 193.77KB
AVH Avita Research Partnership with University of HuddersfieldPRICE SENSITIVE17/08/15 download Created with Sketch. 95.48KB
AVH Avita Medical Quarterly ReportPRICE SENSITIVE29/07/15 download Created with Sketch. 188.7KB
AVH Avita's ReCell featured in US Army Technoloigy MagazinePRICE SENSITIVE20/07/15 download Created with Sketch. 185.45KB
AVH ReCell demonstrates 78% Repigmentation Compared to controlPRICE SENSITIVE06/07/15 download Created with Sketch. 79.24KB
AVH Avita Secures 2nd US Patent ApplicationPRICE SENSITIVE17/06/15 download Created with Sketch. 87.69KB
AVH ReCell featured at important US Government SymposiumPRICE SENSITIVE21/05/15 download Created with Sketch. 102.32KB
AVH New U.S. Patent for ReCellPRICE SENSITIVE13/05/15 download Created with Sketch. 98.64KB
AVH Avita Quarterly Report and Appendix 4CPRICE SENSITIVE29/04/15 download Created with Sketch. 176.88KB
AVH EU CE Mark Granted for Expanded ReCell DevicePRICE SENSITIVE27/04/15 download Created with Sketch. 98.31KB
AVH Appointment of Adam Kelliher as Chief Executive OfficerPRICE SENSITIVE14/04/15 download Created with Sketch. 102.54KB
AVH Completes $5m Placement and Share Purchase Plan OfferPRICE SENSITIVE12/03/15 download Created with Sketch. 85.83KB
AVH Trading HaltPRICE SENSITIVE10/03/15 download Created with Sketch. 155.39KB
AVH Half Yearly Report and AccountsPRICE SENSITIVE27/02/15 download Created with Sketch. 529KB
AVH Quarterly Report and Appendix 4CPRICE SENSITIVE30/01/15 download Created with Sketch. 126.41KB
AVH Patient Enrolment in US Pivotal Phase IIIl ReCell TrialPRICE SENSITIVE28/01/15 download Created with Sketch. 102.6KB
AVH Avita Medical Provides NICE Guidance Recommendation UpdatePRICE SENSITIVE13/11/14 download Created with Sketch. 94.3KB
AVH Avita Medical receives $1.4 Million R&D Tax IncentivePRICE SENSITIVE11/11/14 download Created with Sketch. 83.8KB
AVH Appendix 4C - quarterlyPRICE SENSITIVE31/10/14 download Created with Sketch. 212.98KB
AVH US FDA approval to modify ReCell TrialPRICE SENSITIVE16/09/14 download Created with Sketch. 129.24KB
AVH Trading HaltPRICE SENSITIVE15/09/14 download Created with Sketch. 80.33KB
AVH Preliminary Final Report FY14PRICE SENSITIVE29/08/14 download Created with Sketch. 359.67KB
AVH Avita Medical Quarterly Report June 2014PRICE SENSITIVE29/07/14 download Created with Sketch. 124.09KB
AVH Positive ReCell repigmentation trial resultsPRICE SENSITIVE11/06/14 download Created with Sketch. 108.13KB
AVHReCell Success in Pigmentation Restoration Aesthetic TiralPRICE SENSITIVE15/05/14 download Created with Sketch. 113.81KB
AVHQuarterly Report - Appendix 4CPRICE SENSITIVE24/04/14 download Created with Sketch. 163.63KB
AVHReCell receives FDA IDE Compassionate use approvalPRICE SENSITIVE10/04/14 download Created with Sketch. 112.06KB
AVHReCell ambient-stored enzyme launched in Europe and UKPRICE SENSITIVE08/04/14 download Created with Sketch. 106.87KB
AVHHalf Yearly Report and AccountsPRICE SENSITIVE28/02/14 download Created with Sketch. 383.71KB
AVHAppendix 4C - quarterlyPRICE SENSITIVE31/01/14 download Created with Sketch. 186.66KB
AVHResponse to ASX QueryPRICE SENSITIVE27/12/13 download Created with Sketch. 146.98KB
AVHAppointment of CEO & ChairmanPRICE SENSITIVE11/12/13 download Created with Sketch. 155.01KB
AVHTrading HaltPRICE SENSITIVE09/12/13 download Created with Sketch. 80.46KB
AVHAppendix 4C - quarterlyPRICE SENSITIVE30/10/13 download Created with Sketch. 106.44KB
AVHPOSITIVE RECELL INTERIM CLINICAL STUDY RESULTSPRICE SENSITIVE18/10/13 download Created with Sketch. 136.63KB
AVHPreliminary Final ReportPRICE SENSITIVE30/08/13 download Created with Sketch. 200.78KB
AVHCompletion of Enrollment for ReCell Vitiligo TrialPRICE SENSITIVE21/08/13 download Created with Sketch. 146.11KB
AVHEnrolment of Patients in Recell Chronic Leg Ulcer TrialPRICE SENSITIVE01/08/13 download Created with Sketch. 346.62KB
AVHQuarterly Report June 2013PRICE SENSITIVE30/07/13 download Created with Sketch. 132.48KB
AVHAppendix 4C - quarterlyPRICE SENSITIVE29/04/13 download Created with Sketch. 121.4KB
AVHJapanese Patent Granted - Expands Commercial RightsPRICE SENSITIVE10/04/13 download Created with Sketch. 135.97KB
AVHHalf Year Report and AccountsPRICE SENSITIVE27/02/13 download Created with Sketch. 266.22KB
AVHAVH Completes CE Mark Recertification and ISO AuditPRICE SENSITIVE13/02/13 download Created with Sketch. 334.99KB
AVHQuarterly Cash Flow Q2 FY13PRICE SENSITIVE29/01/13 download Created with Sketch. 187.88KB
AVHChronic Wound Research underway within key EU MarketsPRICE SENSITIVE20/11/12 download Created with Sketch. 133.95KB
AVHAppendix 4C - quarterlyPRICE SENSITIVE31/10/12 download Created with Sketch. 119.9KB
AVHAvita secures additional funding from US Dept of DefencePRICE SENSITIVE28/09/12 download Created with Sketch. 255KB
AVHCapital RaisingPRICE SENSITIVE05/09/12 download Created with Sketch. 100.08KB
AVHTrading HaltPRICE SENSITIVE03/09/12 download Created with Sketch. 18.83KB
AVHPreliminary Final ReportPRICE SENSITIVE31/08/12 download Created with Sketch. 198.39KB
AVHAvita Announces Manufacturing AdvancesPRICE SENSITIVE27/08/12 download Created with Sketch. 138.31KB
AVHJune Quarterly Report FY12PRICE SENSITIVE31/07/12 download Created with Sketch. 115.27KB
AVHShareholder UpdatePRICE SENSITIVE30/07/12 download Created with Sketch. 2.5MB
AVHFDA Study for Cosmetic IndicationsPRICE SENSITIVE10/05/12 download Created with Sketch. 138.68KB
AVHQuarterly ReportPRICE SENSITIVE27/04/12 download Created with Sketch. 124.93KB
AVHAvita granted EU PatentPRICE SENSITIVE05/04/12 download Created with Sketch. 102.96KB
AVHSuccessfully completes ISO Quality RecertificationPRICE SENSITIVE09/02/12 download Created with Sketch. 104.7KB
AVHAppendix 4C - quarterlyPRICE SENSITIVE31/01/12 download Created with Sketch. 114.75KB
AVHReCell Expansion of Sales into ItalyPRICE SENSITIVE01/12/11 download Created with Sketch. 185.84KB
AVHIP Transfer CompletedPRICE SENSITIVE29/11/11 download Created with Sketch. 186.44KB
AVHAppendix 4C - quarterlyPRICE SENSITIVE28/10/11 download Created with Sketch. 121.89KB
AVHLaunches ReCell for Treatment of Chronic UlcersPRICE SENSITIVE13/10/11 download Created with Sketch. 196.74KB
AVHReCell JV Middle East and North Africa LaunchPRICE SENSITIVE07/09/11 download Created with Sketch. 173.51KB
AVHPreliminary Final ReportPRICE SENSITIVE31/08/11 download Created with Sketch. 220.23KB
AVHFDA ReCell Approval Received for Study Cosmetic IndicationsPRICE SENSITIVE25/08/11 download Created with Sketch. 151.9KB
AVHAppendix 4C - quarterlyPRICE SENSITIVE01/08/11 download Created with Sketch. 147.6KB
AVHReCell at Cosmedica Germany and USA Regenerative ForumPRICE SENSITIVE07/06/11 download Created with Sketch. 186.42KB
AVHShare Purchase Plan OfferPRICE SENSITIVE20/05/11 download Created with Sketch. 409.85KB
AVHEquity Raising and La Jolla Convertible Note terminationPRICE SENSITIVE17/05/11 download Created with Sketch. 111.65KB
AVH Burns Research presented at UK Skin Regeneration Symposium-AVH.AX
19/04/16PRICE SENSITIVE download Created with Sketch. 76.47KB
AVH Avita completes Enrollment for Repigmentation Study
15/03/16PRICE SENSITIVE download Created with Sketch. 124.6KB
AVH Signs China Distributor Deal with largest healthcare Group
11/03/16PRICE SENSITIVE download Created with Sketch. 60.63KB
AVH Positive Results from Multicentre EU Study Venous Leg Ulcers
09/03/16PRICE SENSITIVE download Created with Sketch. 137.57KB
AVH FDA increases Compassionate Use of ReCell Patient Cases
07/03/16PRICE SENSITIVE download Created with Sketch. 58.32KB
AVH Half Year Report and Accounts
26/02/16PRICE SENSITIVE download Created with Sketch. 465.21KB
AVH ReCell Distributor appointed Germany Austria and Switzerland
11/02/16PRICE SENSITIVE download Created with Sketch. 102.17KB
AVH Divestment of Respiratory Business
05/02/16PRICE SENSITIVE download Created with Sketch. 118.98KB
AVH Avita Medical Quarterly Cashflow Activities and Report
28/01/16PRICE SENSITIVE download Created with Sketch. 150.1KB
AVH Avita Medical Appoints Distributors in Japan and South Korea
14/01/16PRICE SENSITIVE download Created with Sketch. 95.84KB
AVH Avita completes FDA patient recruitment for ReCell Trial
11/01/16PRICE SENSITIVE download Created with Sketch. 486.1KB
AVH MVP acquires Avita Medicals Australian Respiratory Business
24/12/15PRICE SENSITIVE download Created with Sketch. 305.58KB
AVH FDA Grants Avita's ReCell Expedited Access Pathway
14/12/15PRICE SENSITIVE download Created with Sketch. 127.84KB
AVH Avita Medical Reports 63% Decreased Length of Hospital Stay
09/12/15PRICE SENSITIVE download Created with Sketch. 125.31KB
AVH Avita Medical appoints ReCell Distributors in UK & France
24/11/15PRICE SENSITIVE download Created with Sketch. 215.55KB
AVH Avita Medical Extends ReCell IP Patent through to 2033
18/11/15PRICE SENSITIVE download Created with Sketch. 289.8KB
AVH Avita Medical Quarterly Report
28/10/15PRICE SENSITIVE download Created with Sketch. 227.1KB
AVH Power of ReCell Results presented at European Burns Congress
27/10/15PRICE SENSITIVE download Created with Sketch. 293.42KB
AVH First Patient Treated in US Military Wound Trial
22/10/15PRICE SENSITIVE download Created with Sketch. 293.17KB
AVH Avita ReCell Findings Published in Leading Medical Journal
21/10/15PRICE SENSITIVE download Created with Sketch. 372.46KB
AVH Avita Medical Closes AUD$10M Equity Financing
20/10/15PRICE SENSITIVE download Created with Sketch. 97.09KB
AVH Trading Halt
16/10/15PRICE SENSITIVE download Created with Sketch. 83.75KB
AVH Avita Medical ReCell Update on Treatment Taiwan Burn Victims
13/10/15PRICE SENSITIVE download Created with Sketch. 228.01KB
AVH Avita Medical Gains CE Mark for its Skin Healing Portfolio
07/10/15PRICE SENSITIVE download Created with Sketch. 304.39KB
AVH FDA Doubles Patient Numbers Permitted for Compassionate Use
05/10/15PRICE SENSITIVE download Created with Sketch. 124.25KB
AVH Avita Medical Secures USD$53.9m Contract
30/09/15PRICE SENSITIVE download Created with Sketch. 103.11KB
AVH Avita Medical Patent Validated in Eleven European Countries
02/09/15PRICE SENSITIVE download Created with Sketch. 115.22KB
AVH Reinstatement to Official Quotation
31/08/15PRICE SENSITIVE download Created with Sketch. 28.02KB
AVH US Mass Casualty Preparedness Achieves High Rating
31/08/15PRICE SENSITIVE download Created with Sketch. 74.64KB
AVH Suspension from Official Quotation
28/08/15PRICE SENSITIVE download Created with Sketch. 28.26KB
AVH Preliminary Final Report
27/08/15PRICE SENSITIVE download Created with Sketch. 148.49KB
AVH Trading Halt
26/08/15PRICE SENSITIVE download Created with Sketch. 193.77KB
AVH Avita Research Partnership with University of Huddersfield
17/08/15PRICE SENSITIVE download Created with Sketch. 95.48KB
AVH Avita Medical Quarterly Report
29/07/15PRICE SENSITIVE download Created with Sketch. 188.7KB
AVH Avita's ReCell featured in US Army Technoloigy Magazine
20/07/15PRICE SENSITIVE download Created with Sketch. 185.45KB
AVH ReCell demonstrates 78% Repigmentation Compared to control
06/07/15PRICE SENSITIVE download Created with Sketch. 79.24KB
AVH Avita Secures 2nd US Patent Application
17/06/15PRICE SENSITIVE download Created with Sketch. 87.69KB
AVH ReCell featured at important US Government Symposium
21/05/15PRICE SENSITIVE download Created with Sketch. 102.32KB
AVH New U.S. Patent for ReCell
13/05/15PRICE SENSITIVE download Created with Sketch. 98.64KB
AVH Avita Quarterly Report and Appendix 4C
29/04/15PRICE SENSITIVE download Created with Sketch. 176.88KB
AVH EU CE Mark Granted for Expanded ReCell Device
27/04/15PRICE SENSITIVE download Created with Sketch. 98.31KB
AVH Appointment of Adam Kelliher as Chief Executive Officer
14/04/15PRICE SENSITIVE download Created with Sketch. 102.54KB
AVH Completes $5m Placement and Share Purchase Plan Offer
12/03/15PRICE SENSITIVE download Created with Sketch. 85.83KB
AVH Trading Halt
10/03/15PRICE SENSITIVE download Created with Sketch. 155.39KB
AVH Half Yearly Report and Accounts
27/02/15PRICE SENSITIVE download Created with Sketch. 529KB
AVH Quarterly Report and Appendix 4C
30/01/15PRICE SENSITIVE download Created with Sketch. 126.41KB
AVH Patient Enrolment in US Pivotal Phase IIIl ReCell Trial
28/01/15PRICE SENSITIVE download Created with Sketch. 102.6KB
AVH Avita Medical Provides NICE Guidance Recommendation Update
13/11/14PRICE SENSITIVE download Created with Sketch. 94.3KB
AVH Avita Medical receives $1.4 Million R&D Tax Incentive
11/11/14PRICE SENSITIVE download Created with Sketch. 83.8KB
AVH Appendix 4C - quarterly
31/10/14PRICE SENSITIVE download Created with Sketch. 212.98KB
AVH US FDA approval to modify ReCell Trial
16/09/14PRICE SENSITIVE download Created with Sketch. 129.24KB
AVH Trading Halt
15/09/14PRICE SENSITIVE download Created with Sketch. 80.33KB
AVH Preliminary Final Report FY14
29/08/14PRICE SENSITIVE download Created with Sketch. 359.67KB
AVH Avita Medical Quarterly Report June 2014
29/07/14PRICE SENSITIVE download Created with Sketch. 124.09KB
AVH Positive ReCell repigmentation trial results
11/06/14PRICE SENSITIVE download Created with Sketch. 108.13KB
AVHReCell Success in Pigmentation Restoration Aesthetic Tiral
15/05/14PRICE SENSITIVE download Created with Sketch. 113.81KB
AVHQuarterly Report - Appendix 4C
24/04/14PRICE SENSITIVE download Created with Sketch. 163.63KB
AVHReCell receives FDA IDE Compassionate use approval
10/04/14PRICE SENSITIVE download Created with Sketch. 112.06KB
AVHReCell ambient-stored enzyme launched in Europe and UK
08/04/14PRICE SENSITIVE download Created with Sketch. 106.87KB
AVHHalf Yearly Report and Accounts
28/02/14PRICE SENSITIVE download Created with Sketch. 383.71KB
AVHAppendix 4C - quarterly
31/01/14PRICE SENSITIVE download Created with Sketch. 186.66KB
AVHResponse to ASX Query
27/12/13PRICE SENSITIVE download Created with Sketch. 146.98KB
AVHAppointment of CEO & Chairman
11/12/13PRICE SENSITIVE download Created with Sketch. 155.01KB
AVHTrading Halt
09/12/13PRICE SENSITIVE download Created with Sketch. 80.46KB
AVHAppendix 4C - quarterly
30/10/13PRICE SENSITIVE download Created with Sketch. 106.44KB
AVHPOSITIVE RECELL INTERIM CLINICAL STUDY RESULTS
18/10/13PRICE SENSITIVE download Created with Sketch. 136.63KB
AVHPreliminary Final Report
30/08/13PRICE SENSITIVE download Created with Sketch. 200.78KB
AVHCompletion of Enrollment for ReCell Vitiligo Trial
21/08/13PRICE SENSITIVE download Created with Sketch. 146.11KB
AVHEnrolment of Patients in Recell Chronic Leg Ulcer Trial
01/08/13PRICE SENSITIVE download Created with Sketch. 346.62KB
AVHQuarterly Report June 2013
30/07/13PRICE SENSITIVE download Created with Sketch. 132.48KB
AVHAppendix 4C - quarterly
29/04/13PRICE SENSITIVE download Created with Sketch. 121.4KB
AVHJapanese Patent Granted - Expands Commercial Rights
10/04/13PRICE SENSITIVE download Created with Sketch. 135.97KB
AVHHalf Year Report and Accounts
27/02/13PRICE SENSITIVE download Created with Sketch. 266.22KB
AVHAVH Completes CE Mark Recertification and ISO Audit
13/02/13PRICE SENSITIVE download Created with Sketch. 334.99KB
AVHQuarterly Cash Flow Q2 FY13
29/01/13PRICE SENSITIVE download Created with Sketch. 187.88KB
AVHChronic Wound Research underway within key EU Markets
20/11/12PRICE SENSITIVE download Created with Sketch. 133.95KB
AVHAppendix 4C - quarterly
31/10/12PRICE SENSITIVE download Created with Sketch. 119.9KB
AVHAvita secures additional funding from US Dept of Defence
28/09/12PRICE SENSITIVE download Created with Sketch. 255KB
AVHCapital Raising
05/09/12PRICE SENSITIVE download Created with Sketch. 100.08KB
AVHTrading Halt
03/09/12PRICE SENSITIVE download Created with Sketch. 18.83KB
AVHPreliminary Final Report
31/08/12PRICE SENSITIVE download Created with Sketch. 198.39KB
AVHAvita Announces Manufacturing Advances
27/08/12PRICE SENSITIVE download Created with Sketch. 138.31KB
AVHJune Quarterly Report FY12
31/07/12PRICE SENSITIVE download Created with Sketch. 115.27KB
AVHShareholder Update
30/07/12PRICE SENSITIVE download Created with Sketch. 2.5MB
AVHFDA Study for Cosmetic Indications
10/05/12PRICE SENSITIVE download Created with Sketch. 138.68KB
AVHQuarterly Report
27/04/12PRICE SENSITIVE download Created with Sketch. 124.93KB
AVHAvita granted EU Patent
05/04/12PRICE SENSITIVE download Created with Sketch. 102.96KB
AVHSuccessfully completes ISO Quality Recertification
09/02/12PRICE SENSITIVE download Created with Sketch. 104.7KB
AVHAppendix 4C - quarterly
31/01/12PRICE SENSITIVE download Created with Sketch. 114.75KB
AVHReCell Expansion of Sales into Italy
01/12/11PRICE SENSITIVE download Created with Sketch. 185.84KB
AVHIP Transfer Completed
29/11/11PRICE SENSITIVE download Created with Sketch. 186.44KB
AVHAppendix 4C - quarterly
28/10/11PRICE SENSITIVE download Created with Sketch. 121.89KB
AVHLaunches ReCell for Treatment of Chronic Ulcers
13/10/11PRICE SENSITIVE download Created with Sketch. 196.74KB
AVHReCell JV Middle East and North Africa Launch
07/09/11PRICE SENSITIVE download Created with Sketch. 173.51KB
AVHPreliminary Final Report
31/08/11PRICE SENSITIVE download Created with Sketch. 220.23KB
AVHFDA ReCell Approval Received for Study Cosmetic Indications
25/08/11PRICE SENSITIVE download Created with Sketch. 151.9KB
AVHAppendix 4C - quarterly
01/08/11PRICE SENSITIVE download Created with Sketch. 147.6KB
AVHReCell at Cosmedica Germany and USA Regenerative Forum
07/06/11PRICE SENSITIVE download Created with Sketch. 186.42KB
AVHShare Purchase Plan Offer
20/05/11PRICE SENSITIVE download Created with Sketch. 409.85KB
AVHEquity Raising and La Jolla Convertible Note termination
17/05/11PRICE SENSITIVE download Created with Sketch. 111.65KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.34
Change
0.010(0.75%)
Mkt cap ! $121.4M
Open High Low Value Volume
$1.34 $1.37 $1.34 $885.1K 655.8K

Buyers (Bids)

No. Vol. Price($)
11 26617 $1.34
 

Sellers (Offers)

Price($) Vol. No.
$1.35 150 1
View Market Depth
Last trade - 16.10pm 05/09/2025 (20 minute delay) ?
Last
$1.35
  Change
0.010 ( 1.50 %)
Open High Low Volume
$1.35 $1.37 $1.34 116745
Last updated 15.59pm 05/09/2025 ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.